To understand the mechanism of regulation of bovine herpesvirus 4 (BHV-4) early gene expression by immediate-early (IE) gene products, we studied activation of expression of the BHV-4 early gene encoding thymidine kinase (TK). BHV-4 encodes two IE RNAs. IE RNA 2 encodes a protein with predicted amino acid sequence similarity to the Epstein-Barr virus ( 
Introduction
Bovine herpesvirus 4 (BHV-4) infection is widespread in cattle in Europe and the United States (Guo et at., 1988; Truman et al., 1986 ), but its relationship with disease is unclear (reviewed in Bartha et al., 1987; Thiry et al., 1989) . DNA sequence analysis indicates that BHV-4 is genetically most closely related to the gammaherpesviruses Epstein-Barr virus (EBV) and herpesvirus saimiri (HVS) . The transcription of BHV-4, like other herpesviruses, is sequentially regulated during infection in vitro and mRNAs are divided into three kinetic classes, immediate early (IE), early (E)and late (L), based on their time of expression (Chang & van Santen, 1992) . IE genes are expressed immediately upon infection and do not require prior virus protein synthesis for their expression. IE gene products activate expression of E and L genes (reviewed in Liebowitz & Kieff, 1993; Roizman & Sears, 1993) .
In BHV-4-infected cells, two cytoplasmic polyadenylated RNAs are transcribed from the BHV-4 genome under immediate-early conditions (Chang & van Santen, 1992; van Santen, 1991 van Santen, , 1993 . The most * Author for correspondence. Fax +1 334 844 2652. e-mail wsanten@mail.auburn.edu abundant IE RNA, IE RNA 1, is a spliced 1.7 kb RNA, which is transcribed from right to left on the restriction map of the BHV-4 genome, from DNA contained in the 8"3 kb HindIII fragment E (Fig. 1) . IE RNA 1 contains genetic information encoding a protein of 284 amino acids which could contain zinc-finger structures near its amino terminus (van Santen, 1991) . The predicted amino acid sequence of the protein encoded by IE RNA 1, IE1, does not exhibit similarity to EBV or HVS proteins. Instead, the amino-terminal portion shows similarity to the non-specific transactivator IEll0 of herpes simplex virus type 1 (HSV-1). The less abundant BHV-4 IE RNA, IE RNA 2, is a spliced, 1.8 kb RNA, which is transcribed from left to right on the restriction map of the BHV-4 genome, from DNA contained in the 8"3 kb HindIII fragment F (van Santen, 1991 (van Santen, , 1993 . The predicted amino acid sequence of the protein encoded by IE RNA 2, IE2, shows similarity with EBV R and HVS.R transcriptional transactivators (van Santen, 1993) .
The EBV R transactivator is a sequence-specific DNAbinding protein which binds DNA as a homodimer (Gruffat et al., 1990 (Gruffat et al., , 1992 Gruffat & Sergeant, 1994; Manet et al., 1991) . Amino-terminal DNA-binding and carboxyI-terminal activation domains of R have been identified (Manet et al., 1991) . Comparison of DNA sequences that bind R has produced an R-recognition 0001-3300 © 1995 SGM L. Zhang and V. L. van Santen site consensus sequence, GNCCN~GGNG (Gruffat & Sergeant, 1994) . Many EBV E promoter-regulatory regions have one or more R-recognition sites and are activated by R (Chavrier et al., 1989 ; Chevallier-Greco et aI., 1989; Cox et al., 1990; Gruffat et al., 1990 Gruffat et al., , 1992 Hardwick et al., 1988 ; Holley-Guthrie et al., 1990) . EBV has an additional IE transactivator, the Z transactivator, another sequence-specific DNA-binding protein (reviewed in Sinclair & Farrell, 1992) . The Z transactivator plays a crucial role in reactivation from latent infection (Countryman et al., 1987; Countryman & Miller, 1985; Rooney et al., 1989) . Most EBV promoterregulatory regions studied have both R and Z response elements, and these two transactivators act together to stimulate EBV E gene expression Chavrier et al., 1989; Chevallier-Greco et al., 1989; Cox et al., 1990; Holley-Guthrie et al., 1990; Kenney et al., 1989; Quinlivan et at., 1993) . Neither BHV-4 nor HVS have a gene homologous to the EBV Z transactivator gene Bublot et al., 1992) . Therefore, activation of BHV-4 and HVS early gene expression might be accomplished by the R transactivator homologues alone, or by the R transactivator homologues in co-operation with a virus transactivator not homologous to the EBV Z transactivator. Transactivation studies show that the BHV-4 IE2 gene product specifically transactivates the promoter-regulatory region of the BHV-4 early gene homologous to the major DNA-binding protein of HSV-1 (van Santen, 1993) . No role for the IE1 gene product in transactivation of this promoter-regulatory region was demonstrated (van Santen, 1993) . In the work presented here, we studied the mechanism of gene regulation by BHV-4 IE gene products using the promoter-regulatory region of the BHV-4 thymidine kinase (TK) gene. The BHV-4 TK gene has been localized and sequenced . It is oriented from left to right in HindIII fragments X, b and G ( Fig. 1 ; Lomonte et al., 1992 ) and encodes an approximately 2 kb E RNA (Chang & van Santen, 1992) .
Methods
Cell culture and virus. The DN-599 isolate of BHV-4 and bovine turbinate (BT) cells (ATCC CRL1390) were used for all experiments. Cell culture and virus propagation were as previously described (van Santen, 1991) . S1 nuclease analysis and primer extension analysis. Cytoplasmic polyadenylated RNA was prepared 12 h post-infection as previously described (van Santen, 1991 ) from cells infected with approximately one 50% tissue culture infective dose (TCIDs0) per cell. SI nuclease analysis and primer extension were performed as previously described (van Santen, 1991) . A 5t-end-labelled synthetic oligonucleotide (5' GGAATGGAAGTTCCAGCCAT 3') complementary to the first 20 nucleotides of the TK open reading frame (ORF) was used to prime synthesis of a 575 nt single stranded probe for S 1 nuclease analysis and a 151 nt single stranded primer for primer extension analysis in a thermocycler using cloned HindIII X fragment as template. The 3" end of the probe and primer were set by cleavage of the template with HindIIl or Dral, respectively. Amplified single stranded probe and primer were purified by electrophoresis in a 6 % denaturing polyacrylamide gel.
Nucleotide sequence analysis. Nucleotide sequence was determined by the dideoxynucleotide chain termination method, using the Sequenase 2.0 sequencing kit (USB) with single stranded phagemid templates.
Target and effector plasmids. Effector plasmid encoding IE2 (pH12PR3.4), negative control plasmid pTZ18U and transfection efficiency control plasmid pSV-fl-Galactosidase used in transient expression cotransfection assays are the same as previously described (van Santen, 1993) . Target  plasmids  pTKRD844CAT,  pTKHD425CAT,  pTKXH317CAT, pTKSH227CAT, pTKDH 155CAT and pTKSD72CAT contain restriction fragments 5' to the TK ORF cloned into the pCAT-Basic vector (Promega) 5' to a promoterless chloramphenicol acetyltransferase (CAT) reporter gene. The numbers in each plasmid name indicate the number of nucleotides in the BHV-4 DNA fragment contained in each construct. The two letters preceding the numbers stand for restriction sites that define each end of the fragment (see Fig. 3 ). The constructs also contain additional nucleotides derived from the multiple cloning region of the pTZ19U vector. The pMDBPAX431CAT contains the 431 bp A vaI-HindlII fragment 5' to the BHV-4 ORF homologous to the HSV-1 major DNA-binding protein gene inserted into pCAT-Basic 5' to the CAT reporter gene. It was derived from pBH1HXI.I-CAT (van Santen, 1993) by deletion of the fragment between unique AvaI and HindIlI sites.
Target plasmids pTKSD72.PCAT, pTKSD72R.PCAT and pTKSD72D.PCAT (see Fig. 4 ) all contain the same 72 bp fragment as pTKSD72CAT, cloned into the pCAT-Promoter vector (Promega). The pTKSD72.PCAT and pTKSD72R.PCAT each contain three copies of the fragment, inserted into the BglII site 5' to the enhancerless simian virus 40 (SV40) early promoter, in forward and reverse orientation, respectively, pTKSD72D.PCAT contains five copies of the fragment, inserted into the BamHI site 3' to the CAT gene in the orientation shown in Fig. 4 .
Transient expression cotransfection assays. Effector and target plasmid DNA was prepared and introduced into BT cells by calcium phosphate-mediated transfection as previously described (van Santen, 1993) with the following changes. The calcium phosphate-DNA copreeipitate was incubated with cells for 15-18 h. After incubation with the calcium pbosphate-DNA coprecipitate, cells were rinsed with Dulbecco's balanced salt solution and the medium was changed only once instead of twice, pSV-fl-Galactosidase control plasmid was included in each transfection to control for transfection efficiency, general transcription efficiency and sample recovery.
Cell extracts to be used for fl-galactosidase and CAT assays were prepared and CAT assays were performed with the phase extraction assay procedure (Seed & Sheen, 1988) as described previously (van Santen, 1993) , with 30 gl cell extract for each assay. The/?-galactosidase assays using a chemiluminescent substrate (Jain & Magrath, 1991) were performed using a Galcto-Light kit (Tropix), with 10 gl cell extract for each assay. The extent of activation was calculated by use of the formula [(CAT activity in the presence of effector)/(/Lgalactosidase activity in the presence of effector)]/[(CAT activity in the absence of effector)/(fl-galactosidase activity in the absence of effector)]. The/3-galactosidase gene was driven by the SV40 early promoter. Use of the ratio of CAT activity to fl-galactosidase activity in calculations corrected the data for transfection efficiency, general transcription efficiency, non-specific transactivatiou and sample recovery. Activation results are presented as the average of several experiments +_ standard error.
In vitro transcription~translation of IE2 protein. Wild-type, fulllength IE2 protein was produced by in vitro translation of IE2 RNA produced by in vitro transcription of pT71E2WT containing IE2 cDNA in pTZ18U (United States Biochemical). The 5' portion of the IE2 cDNA in pT7IE2WT was derived from the unnamed IE2 cDNA clone described by van Santen (1993) and the 3' portion was derived from cloned genomic DNA, nucleotides 2258M039 of the published sequence (van Santen, 1993) . The unnamed cDNA clone contained a single base change compared to genomic DNA, presumably derived from PCR error. This nucleotide was changed back to wild-type by oligonucleotide-directed site-specific mutagenesis using uracil-containing single stranded phagemid template DNA produced in Escherichia coli strain RZ1032 (Sambrook et al., 1989) . The uncorrected cDNA clone was named pT7IE2-36F because the mutation resulted in phenylalanine as the 36th amino acid, rather than serine as in wild-type. Truncated IE2 was produced by in vitro transcription/translation of pT7IE2RS, which contained a 1229 bp EcoRI-SmaI fragment derived from pT71E2WT cloned into pTZ18U, pT7IE2RS contains only the first 401 codons of the 551 amino acid IE2 protein.
IE2 protein was produced in vitro either by separate in vitro transcription and translation reactions (see Fig. 5 a, b, [~H] leucine in the reaction and the reaction products were examined by SDS-PAGE prior to use in gel retardation assays. For coupled in vitro transcription/translation reactions, 1 gg of uncleared pT7IE2WT or pT7IE2RS was transcribed and translated using a TNT coupled reticulocyte lysate system kit (Promega) following instructions provided by the manufacturer.
Gel retardation assay. To produce labelled DNA fragments for gel retardation assays, cloned DNA and a fragment generated by PCR were cleaved at appropriate sites with restriction enzymes and 3'-endlabelled with [c~-a"P]dCTP by repair of ends with the Klenow fragment of E. coli DNA polymerase I. Gel retardation assays were performed as described by Gruffat et al. (1990) , except 4 x 10 ~ c.p.m. 32P-labelled DNA fragment and 1 pg poly[d(l-C)] were added to each 15 gl of binding reaction. For competition experiments, the amount of labelled and unlabelled DNA fragment was compared by visualization of ethidinm bromide-staining of DNA after electrophoresis in a polyacrylamide gel.
Results

Mapping the 5' end of TK RNA
S I nuclease analysis was used to map the transcription start site for TK RNA ( We determined the nucleotide sequence of BHV-4 strain DN-599 D N A surrounding the start of transcription for T K RNA, from approximately -2 1 1 to +217 relative to the major start of transcription. This represents nucleotides 419-847 of the BHV-4 V.Test strain T K D N A sequence published by Lomonte et al. (1992) . Our DN-599 nucleotide sequence (data not shown) is identical to the V.Test sequence with the exception of nucleotide 762 which is A in DN-599 and G in V.Test. This difference results in a HincII site (shown in Fig. 3 ) in the D N A encoding the 5' untranslated region of the TK R N A in DN-599, but not in V.Test. Nucleotide sequence numbers in the present article are based on the published V.Test TK sequence .
The promoter-regulatory region of BHV-4 TK is transactivated by IE2
To examine transactivation of the BHV-4 T K gene, an 844 bp fragment (nt 1-844), containing sequences from approximately -6 2 9 to +215 relative to the start of transcription, was inserted 5' to a promoterless CAT gene in the pCAT-Basic vector (Promega) to create p T K R D 8 4 4 C A T (Fig. 3, line l) . In transient expression cotransfection assays, BHV-4 infection of cells transfected with p T K R D 8 4 4 C A T and control plasmid pSV-flGalactosidase resulted in an increase of both CAT and flgalactosidase activities. However, CAT activity increased 87 + 26-fold while fl-galactosidase activity increased only 2.9+0-6-fold. Therefore the 844 bp fragment contains sequences sufficient for specific activation of expression in BHV-4-infected cells. To determine whether IE2 activates expression from the T K promoter-regulatory region, IE2 effector plasmid was cotransfected with the target plasmid. IE2 transactivated the T K promoterregulatory region 9 +_ 1-fold.
Localizing the IE2 response element within the TK promoter-regulatory region
To determine the approximate location of the IE2 response element(s), progressively smaller fragments were inserted 5' to the CAT reporter gene in the pCATBasic vector and the ability to be transactivated by IE2 was determined using transient expression cotransfection assays (Fig. 3) . The pCAT-Basic vector without inserted D N A sequences was not transactivated by IE2 (data not shown). The apparent increase in fold transactivation by IE2 of p T K X H 3 1 7 C A T (Fig. 3, line 3) compared to p T K H D 4 2 5 C A T (Fig. 3, line 2 ) was the result of lower CAT activity in the absence of IE2 rather than higher CAT activity in the presence of IE2. The average relative CAT activity produced by all the constructs shown in Fig. 3 , with the exception of p T K D H 1 5 5 (Fig. 3, line 5 ), in the presence of IE2 was similar, varying by less than 2-fold. The abrupt decrease in transactivation by IE2 and relative CAT activity in the presence of IE2 when nucleotides 534-605 were deleted (Fig. 3 , compare lines 4 and 5) suggests that an IE2 response element(s) lies in the 72 bp fragment between nucleotides 534 and 605. Alternatively, the absence of stimulation by IE2 of CAT activity produced from the plasmid lacking the 72 bp fragment could be due to loss of basal promoter elements necessary for efficient expression. That the 72 bp frag- ment contains an IE2 response element was confirmed by showing that the 72 bp fragment inserted into the pCATBasic vector is sufficient for transactivation by IE2 (Fig.  3, line 6 ). The pCAT-Basic vector contains no promoter sequences; therefore this 72 bp fragment also contains promoter sequences sufficient for efficient expression. Levels of CAT expression from the reporter gene construct containing the 72 bp fragment in the presence of IE2 were similar to levels of CAT expression from reporter gene constructs containing longer portions of BHV-4 DNA (Fig. 3 , compare lines 1-4 and 6).
Sau3AI EcoRI
Enhancer properties of the IE2 responsive element
To determine whether the IE2 response element(s) in the 72 bp fragment (nt 534--605) possesses enhancer properties, i.e. orientation and distance independence, we inserted the fragment into the pCAT-Promoter vector, which contains the enhancerless SV40 early promoter linked to the CAT gene (Fig. 4) . The pCATPromoter without the inserted fragment was not transactivated by IE2 (data not shown). When inserted 5' to the SV40 promoter, approximately 140 bp 5' to the major S¥40 early RNA transcription start site, three copies of the 72 bp fragment mediated transactivation by IE2 in either orientation (Fig. 4a, b) . The ability of a single copy of the 72bp fragment to confer IE2 responsiveness to the heterologous promoter was not tested. When five copies of the 72 bp fragment were inserted 3' to the CAT gene, a position which is also 2-9 kb 5' to the CAT gene in the circular plasmid, IE2 transactivation was reduced to only 3+0"3-fold (Fig.  4c ).
IE2 forms a complex with the 72 bp fragment that contains the IE2 response element
To determine whether IE2 forms a complex with the IE2 response element in the 72 bp fragment, IE2 protein was produced by in vitro transcription of IE2 cDNA followed by in vitro translation in a reticulocyte lysate. Unfractionated reticulocyte lysate containing in vitrotranslated IE2 was used in gel retardation assays with radiolabelled double stranded 72 bp fragment. Products of an in vitro translation reaction without the addition of exogenous RNA were used as a negative control. Several complexes were formed between the DNA fragment and proteins in the reticulocyte lysate without IE2 (Fig. 5 a,  lane 2) . However, in the presence of in vitro-translated IE2, an additional, more slowly migrating complex was formed (Fig. 5a, lane 3) . That this complex is sequencespecific was demonstrated in two ways. First, a pCATPromoter vector DNA fragment did not form specific complexes in the presence of IE2; the vector fragment formed identical complexes in the presence and absence of IE2 (see Fig. 5a , lanes 5 and 6; two of the complexes between vector DNA fragment and reticulocyte lysate proteins appear IE2-specific in this photograph; however, these complexes are also clearly visible in lane 5 in the original autoradiograph and are therefore not IE2-specific). Second, competition assays showed that the unlabelled 72 bp fragment competed with the labelled 72 bp fragment for formation of the IE2-specific complex (Fig. 5b, lanes 4~7) , whereas an unlabelled pTZ19U vector fragment did not (Fig. 5b, lanes 8-11) .
To demonstrate that the specific DNA-protein complex formed with the 72 bp fragment in the presence of IE2 protein contained IE2 protein, truncated IE2 protein was used in gel retardation assays. If IE2 protein is part of the complex, a smaller IE2 protein should result in a more rapidly migrating complex. Based on amino acid sequence similarity with the EBV R transactivator, the template for truncated IE2 protein was designed so that the truncated protein would contain the putative DNAbinding and dimerization domains. However, no specific complex between the truncated IE2 protein and the 72 bp fragment was observed (Fig. 5 d, lane 4) . In spite of this, when wild-type and truncated templates were mixed prior to in vitro transcription/translation so that heterodimers between wild-type and truncated IE2 protein could form, a more rapidly migrating DNA protein complex was observed, in addition to a complex with the same mobility as that formed with wild-type IE2 (Fig. 5d, lane 6) . The ratio of the amount of the two complexes is consistent with the more rapidly migrating complex containing heterodimers of wild-type and truncated IE2. These results suggest that IE2 protein is present in the complexes with the 72 bp fragment, and that IE2 protein, like the EBV R transactivator, binds DNA as a dimer. The absence of complexes with a heterodimer when wild-type and truncated IE2 proteins are mixed together after synthesis (Fig. 5d, lane 5) suggests that IE2 protein can form stable dimers in the absence of DNA. One possible explanation for the absence of a detectable DNA-protein complex with truncated IE2 dimers (Fig. 5d, lanes 4 and 6) is that it comigrates with the complex observed with proteins in the in vitro translation extract in the presence or absence of IE2, visible in lanes 2-6. Alternatively, perhaps portions of IE2 absent in the truncated protein interact with other proteins present in the complex that stabilize the complex. In this model, one copy of this portion, in the wild-type molecule of the heterodimer, would be sufficient to stabilize the complex so it could be detected by gel retardation assay.
Mutant IE2 protein containing a phenylalanine residue instead of serine in position 36 was unable to form a complex with the 72 bp fragment (Fig. 5c, lane 3) . SDS-PAGE of in vitro translation products showed similar levels o f wild-type a n d m u t a n t p r o t e i n s ( d a t a n o t shown). H o w e v e r , the stability o f w i l d -t y p e a n d m u t a n t p r o t e i n s d u r i n g the gel r e t a r d a t i o n assay was n o t c o m p a r e d . W h e n this m u t a t i o n was i n t r o d u c e d into the I E 2 e x p r e s s i o n p l a s m i d a n d tested in transient e x p r e s s i o n c o t r a n s f e c t i o n assays, m u t a n t I E 2 was also u n a b l e to t r a n s a c t i v a t e the T K I E 2 r e s p o n s e e l e m e n t in vivo ( d a t a n o t shown). T h e r e f o r e , the inability o f m u t a n t I E 2 to f o r m a c o m p l e x w i t h the T K IE2 r e s p o n s e e l e m e n t #7 vitro a p p a r e n t l y results in a n inability to t r a n s a c t i v a t e in vivo. H o w e v e r , the a m o u n t s o f wild-type a n d m u t a n t p r o t e i n s in t r a n s f e c t e d cells were n o t c o m p a r e d .
T K I E 2 response e l e m e n t f o r m s c o m p l e x e s with I E 2 p r o t e i n less efficiently than other B H V -4 I E 2 response e l e m e n t s
In e x p e r i m e n t s w i t h three o t h e r B H V -4 I E 2 -r e s p o n s i v e p r o m o t e r -r e g u l a t o r y regions, we n o t i c e d t h a t the o t h e r
I E 2 -r e s p o n s i v e p r o m o t e r -r e g u l a t o r y regions were acti- (Table  1) . Even though basal levels of expression from all plasmids were similar, IE2-activated expression from the M D B P promoter-regulatory region was more than 30 times that of IE2-activated expression from the T K promoter-regulatory region. Less efficient activation of the T K promoter-regulatory region could be due to less efficient interaction of IE2 protein with the T K IE2 response element than with other IE2 response elements.
To test the relative efficiency of complex formation between IE2 protein and several 1E2 response elements in vitro, fragments c o n t a i n i n g the IE2 response elements of the T K , M D B P and L1.7 promoters were labelled to similar specific activities by cleavage with the same restriction enzyme and addition of a radioactive nucleo-tide with the Klenow fragment of DNA polymerase I. Gel retardation assays were performed with each of the three labelled fragments plus increasing amounts of an unlabelled 72bp fragment containing the TK IE2 response element (Fig. 6 ). Although no difference in the ability of the TK IE2 response element to compete with each labelled DNA fragment for IE2 complex formation was noted, at each concentration of competitor, the amount of labelled TK IE2 response element DNA fragment in the complex was less than the other two IE2 response elements. This result suggests that the IE2 protein forms complexes with the TK IE2 response element less efficiently than with the other two IE2 response elements, but does not rule out the contributions of other factors to the reduced efficiency of activation of the TK IE2 response element when compared to other IE2 response elements in cotransfection assays.
Location of the IE2-binding site within the 72 bp fragment
To determine which sequences within the 72bp fragment were necessary and sufficient for interaction with IE2, gel retardation assays were performed using subfragments of the 72 bp fragment. The results (Fig. 7) indicate that a 14 bp segment, present in fragments D and E, but absent in fragment F (see Fig. 7 b) , contains sequences necessary for complex formation. A 25 bp segment of the TK promoter-regulatory region, contained in fragment E, contains sequences sufficient for IE2 complex formation. However, the amount of IE2-bound fragment was consistently less for fragment E than for fragments containing more of the TK promoterregulatory region. In addition, these 25 bp, when used in gel retardation assays without attached vector sequences (between XbaI and EcoRI sites of multiple cloning region of pTZ18U), were unable to form a complex with IE2 (not shown), suggesting that vector-derived sequences participate in complex formation. However, these vector sequences are not sufficient for IE2 complex formation, because fragment F, linked to the same vector-derived sequences, did not form a complex with IE2. This confirms that specific sequences, derived from the TK promoter-regulatory region, are required for complex formation. The vector sequences could be required to furnish specific bases or could be required to extend the length of DNA present beyond the IE2 recognition site in the 25 bp fragment, perhaps stabilizing a DNA structure suitable for IE2 complex formation.
Discussion
Nucleotide sequence analysis of the DNA encoding IE2 reveals that it could encode a 61 kDa protein with amino acid sequence similarity to the EBV transactivator R and its homologue in HVS (van Santen, 1993) . Previous studies showed that IE2 is indeed a transactivator and transactivates expression from the promoter-regulatory region of the BHV-4 homologue of the HSV major DNA-binding protein (van Santen, 1993) . Our study presented here identifies an additional target of IE2 transactivation. In contrast to the extremely high level of transactivation of three other BHV-4 promoter-regulatory regions examined, which are all transactivated by IE2 more than 100-fold (van Santen, 1993 (Gruffat et al., 1990 (Gruffat et al., , 1992 Manet et al., 1991; Quinlivan et al., 1993) , but apparently does not form complexes with at least one EBV promoter-regulatory region that is activated at a relatively low level by R (Zalani et al., 1992) . Therefore, we performed gel retardation assays with the DNA fragment containing the BHV-4 TK IE2 response element(s) to determine whether the weaker response to IE2 of the TK IE2 response element(s) is due to activation by a mechanism not involving complex formation. However, IE2 formed a readily detectable specific complex with the 72 bp fragment containing the TK IE2 response element. Therefore, this approach did not provide evidence that the mechanism of IE2 transactivation of the TK promoter-regulatory region is different to the mechanism of activation of other, more strongly activated, BHV-4 promoter-regulatory regions. A similar situation exists among EBV promoter-regulatory regions activated by the EBV R transactivator. At least one EBV promoter-regulatory region that binds R is activated by R to a lesser degree than other Rresponsive promoters examined (Quinlivan et al., 1993) . Gel retardation experiments comparing IE2-binding to L. Zhang and V. L. van Santen (a) DNA fragment: a) . Gel retardation assays of fragments A and D were electrophoresed on the same gel; gel retardation assays with fragments B, E and F were electrophoresed on a different gel; and the gel retardation assay with fragment C was electrophoresed on a third gel, which also included positive controls. Unbound fragment C ran off the gel. Arrowheads indicate IE2-specific complexes. The dsDNA sequence of fragment A is indicated at the top of (b EBV R response elements function as R-responsive enhancer elements; they function in either orientation and independently of distance from the promoter Chevallier-Greco et al., 1989; Cox et al., 1990; Kenney et al., 1989) . The TK IE2 response element also has enhancer-like properties. It can transfer IE2-responsiveness to a heterologous promoter in either orientation. However, we have not been able to confer IE2-responsiveness on a heterologous promoter by insertion of DNA fragments that bind IE2 in vitro from the three other IE2 responsive BHV-4 promoter-regulatory regions examined (V. van Santen, unpublished results; R. Bermudez-Cruz & V.L. van Santen, unpublished results). Perhaps the ability of the TK IE2 response element to function in either orientation is related to a role in activation of transcription of an RNA containing the B H V -4 0 R F homologous to the EBV BVRF10RF. This BHV-40RF begins 56 bp 5' to the 72 bp fragment containing the TK IE2 response element and is oriented in the opposite direction to the TK ORF . The RNA containing this ORF has not been identified and regulation of its expression has not been examined.
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Because the TK IE2 response element responds weakly to IE2, it is difficult to determine whether, like EBV R response elements, it can function at a greater distance from the promoter. When placed 2 kb 5' to the SV40 early promoter, the TK IE2 response element mediates a 3-fold transactivation by IE2. It is not possible to determine whether this marginal activity represents an abolition of activity or a reduction in efficiency of transactivation at a distance. Our gel retardation assays do not enable us to determine whether IE2 binds directly to DNA or whether complex formation is mediated by host cell proteins present in the reticulocyte lysate used for translation of IE2. However, the EBV R transactivator binds directly to target sequences; a purified glutathione-S-transferase-EBV R fusion protein specifically binds R binding sites (Gruffat & Sergeant, 1994) . Comparison of the nucleotide sequence of the 25 bp fragment containing the TK IE2-binding site with the nucleotide sequence of fragments containing IE2-binding sites from other BHV-4 IE2-responsive promoter-regulatory regions has not enabled identification of an IE2 recognition site consensus sequence. The IE2 response element sequence differs from the EBV R transactivator response element because EBV R does not transactivate an IE2-responsive BHV-4 promoter-regulatory region and vice versa (van Santen, 1993) . Consistent with this, no sequence matching the EBV R consensus binding site (GNCCN~GGNG; Gruffat & Sergeant, 1994 ) is found in the 25 bp TK IE2-binding fragment, nor in IE2-binding fragments from other BHV-4 promoter-regulatory regions. The BHV-4 IE2 recognition sequence might differ from the EBV R recognition sequence as a result of the lower G + C content of the long central non-repetitive portion of the BHV-4 genome (approximately 40%; Bublot et al., 1992) compared to EBV (approximately 60 %; Kieff & Liebowitz, 1990) . Because IE2, like EBV R, apparently binds DNA as a homodimer, the recognition site might be palindromic. If the spacing between bases essential for IE2 recognition and binding is the same as for EBV R, the two parts of the palindrome would be separated by 9 bp. The only sequences in the 24 bp TK IE2-binding fragment meeting those criteria are GGNgCC and ATN9AT. However, these two sequences are not found in all of the other BHV-4 IE2-binding fragments we have identified. Identification of the IE2 recognition site will require further experiments, such as mutagenesis.
A single amino acid substitution in IE2 at position 36 abolished both complex formation in vitro and transisolated after cleavage in vector sequences with Xbal and PstI. Vector sequences included in fragments E and F used for gel retardation are not shown in (b) . Fragments that form IE2-specific complexes are shown as dark bars; fragments that do not form IE2-specific complexes are shown as grey bars. activation activity in vivo. This has also been demonstrated for the three other IE2 response elements examined (V. van Santen, unpublished results; R. Bermudez-Cruz & V.L. van Santen, unpublished results). Amino acid 36 falls within the portion of IE2 homologous to the DNA-binding and dimerization domains of the EBV R transactivator (Manet et al., 1991 ; van Santen, 1993) . When the amino acid sequence of IE2 is aligned with EBV R or HVS.R using the FASTA program (Pearson & Lipman, 1988) , IE2 amino acid 36, a serine, is aligned with a serine residue in HVS.R and a valine residue in EBV R. Our results suggest that this serine residue is important for DNA binding by IE2. However, we have not ruled out the possibility that the mutation interferes with dimerization, overall protein conformation, and/or protein stability.
We have identified a 72 bp fragment 5' to the BHV-4 TK gene that is sufficient for both basal and IE2-activated gene expression. It is able to form a complex with IE2 in vitro and transfers IE2 responsiveness to a heterologous promoter in either orientation. It is located approximately 25 bp 5' to the start of transcription of TK E RNA. The putative TATA box previously identified based on DNA sequence alone is not the functional TATA box, because it is located approximately 80 bp 3' to the 5' end of the TK RNA identified by S1 nuclease analysis and primer extension analysis. The near-100% conservation of nucleotide sequence in the 5' untranslated region and sequences 5' to the start of transcription of TK RNA between V.Test and DN-599 isolates is probably due to the fact that this region encodes an ORF on the opposite strand homologous to the EBV B X R F 1 0 R F . The single base difference results in an alanine codon in V.Test and a valine codon in DN-599. The 72 bp fragment containing the IE2 response element is located entirely within this BXRFl-homologous ORF. Therefore, the sequences regulating transcription of the BHV-4 TK gene are located within the protein-coding sequence of another gene.
We have been unable to demonstrate a role for IE1 in activation of transcription from the BHV-4 TK promoter, as well as two other E and one L promoterregulatory regions examined, using transient expression cotransfection assays (L. Zhang, R. Bermudez-Cruz & V.L. van Santen, unpublished results; van Santen, 1993) . However, we have not shown that IE1 protein is actually produced from IE1 effector plasmid during transient expression cotransfection assays, although correctly spliced IE1 RNA is produced (van Santen, 1993) .
